Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Technology Scientific & Technical Instruments
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and... see more

Recent & Breaking News (NYSE:BIO)

ImmunoGenesis Announces Publication of Phase 1 Data on its Hypoxia-Reversal Agent Highlighting Efficacy and Genetic Expression Correlatives in Advanced Cancer

PR Newswire June 16, 2021

Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And Announces New Board Members

PR Newswire June 16, 2021

New study confirms that social determinants of health challenges are prevalent among commercially-insured populations

PR Newswire June 16, 2021

Dovetail Genomics Announces New Capture Hi-C Targeted Enrichment Panels

PR Newswire June 16, 2021

Molecular Assemblies Expands Executive Leadership Team

PR Newswire June 16, 2021

GT Biopharma to Present at Raymond James Human Health Innovation Conference

PR Newswire June 16, 2021

Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Program Call for Submissions to Support Research in Immuno-oncology

PR Newswire June 16, 2021

Cold Chain Technologies Announces Further Global Expansion Into Latin America

PR Newswire June 16, 2021

Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education Services

PR Newswire June 16, 2021

KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline

PR Newswire June 16, 2021

Elanco Announces Agreement to Acquire Kindred Biosciences

PR Newswire June 16, 2021

United Therapeutics Announces FDA Acceptance of Tyvaso DPI(TM) New Drug Application For Priority Review

PR Newswire June 16, 2021

Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance Novel Biotherapies for Cancer Treatment

PR Newswire June 16, 2021

Mnemo Therapeutics Announces Euro75 million Series A to Accelerate Next Generation Integrated CAR-T and Epigenetic Targeting Platform

PR Newswire June 16, 2021

Totient, a Viva Biotech Portfolio Company, has been Acquired by AbSci

PR Newswire June 15, 2021

Protagonist Therapeutics Announces Pricing of $115 Million Upsized Public Offering of Common Stock

PR Newswire June 15, 2021

FDA Approves StrataGraft for the Treatment of Adults with Thermal Burns

PR Newswire June 15, 2021

MOBILion Systems Launches MOBIE: The First SLIM-Based High-Resolution Ion Mobility (HRIM) Product to Accelerate Biotherapeutic Drug Development and Multiomic Biomarker Discovery

PR Newswire June 15, 2021

AffyImmune Therapeutics Announces Addition of Dr. Jim Mulé to its Scientific Advisory Board

PR Newswire June 15, 2021

Lightspeed Microscopy, Inc. raises $4M in Series A Financing Round with Plans to Revolutionize Pathology

PR Newswire June 15, 2021